CREATIVE BIOMART RECOMBINANT PROTEINS
DEAD

Serial Number

87066966

Owner

Creative BioMart, Inc.

Attorney

David Lin

First Use Date

Jan 1, 2006

Filing Date

Jun 10, 2016

Add to watchlist:

No watchlists yet
View on USPTO

CREATIVE BIOMART RECOMBINANT PROTEINS Trademark

Serial Number: 87066966 • Registration: 5136522

CREATIVE BIOMART RECOMBINANT PROTEINS is a trademark filed by Creative BioMart, Inc. on June 10, 2016. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Creative BioMart, Inc. (3 trademarks)

45-1 Ramsey Rd.
Shirley, NY 11967

Entity Type: 03

Trademark Details

Filing Date

June 10, 2016

Registration Date

February 7, 2017

First Use Anywhere

January 1, 2006

First Use in Commerce

January 1, 2006

Published for Opposition

November 22, 2016

Cancellation Date

August 18, 2023

Goods & Services

Bacteriological consultation and research; Bacteriological research and testing; Biochemical research and development; Biological research; Biomedical research services; Biotechnology research; Chemical analysis; Chemical engineering; Chemical laboratories; Chemical research; Chemical, biochemical, biological and bacteriological research and analysis; Chemist services; Chemistry consultation; Compiling data for research purposes in the field of medical science and medical consultancy; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Custom design and development of chemical reagents and biochemical assays; Design and testing of new products for others; Design, engineering, research, development and testing services in the field of polymeric materials, polymer synthesis, and materials customization for medical, scientific, and technological applications; Development and test of chemical production methods; Development of pharmaceutical preparations and medicines; DNA analysis services for scientific research purposes; Drug discovery services; Executing of chemical analyses; Genetic mapping for scientific purposes; Genetic testing for scientific research purposes; Genetic testing of laboratory animals for research purposes; Laboratory analysis in the field of bacteriology, chemistry, and cosmetics; Laboratory research services relating to pharmaceuticals; Laboratory services, namely, pigment and color analysis; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research information in the field of drug discovery; Medical laboratory services; Medical research; Medical research services in the field of cancer; Performance of chemical analyses; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Product testing; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto; Research and development in the field of drug discovery; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of new products for others; Research and development of technology in the field of drug discovery; Research in the field of chemistry; Research on the subject of pharmaceuticals; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Scientific investigations for medical purposes; Scientific laboratory services; Scientific research; Scientific research and development; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of drug discovery, medicine, the prevention, treatment and management of illness, health care delivery, and cancerous diseases; Scientific research in the field of genetics and genetic engineering

Filing History

CANCELLED SEC. 8 (6-YR)
Aug 18, 2023 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 7, 2022 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 8, 2018 TCCA
REGISTERED-PRINCIPAL REGISTER
Feb 7, 2017 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 22, 2016 NPUB
PUBLISHED FOR OPPOSITION
Nov 22, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 2, 2016 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 15, 2016 PREV
ASSIGNED TO LIE
Oct 15, 2016 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 29, 2016 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 27, 2016 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 27, 2016 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 27, 2016 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 27, 2016 CNEA
ASSIGNED TO EXAMINER
Sep 21, 2016 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jun 18, 2016 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 17, 2016 NWOS
NEW APPLICATION ENTERED
Jun 14, 2016 NWAP